Nomark Ministries

PositiveID Corporation and Siemens AG Enter Into Agreement

DELRAY BEACH, Fla.,

(GLOBE NEWSWIRE) --

("PositiveID") (Nasdaq:PSID), the leader in next generation patient monitoring, announced today that it has entered into an agreement with

("Siemens") related to its Wireless Body™ platform. The license agreement allows

to expand its personalized medicine and smart healthcare applications for next generation patient monitoring and includes granting

rights to utilize key intellectual property, and, in particular,

Patent No. 7,650,888, titled "Method and System for Identification of a Medical Implant" using RFID (radio frequency identification). 

focus is to use the technology to improve disease management and overall wellness through the effortless identification of implantable medical devices within the body. This application expands

Wireless Body, an integrated, in vivo and external, smart healthcare communication system that has the ability to deliver personalized medical solutions wirelessly.

The Wireless Body communication system is based on

Patent No. 7,125,382 for an Embedded Bio-Sensor System, and builds upon existing technology and intellectual property portfolio of

, the developer of the world's first and only health-related implantable RFID microchip cleared by the

. The Wireless Body platform will be designed to enhance wellness and disease management, for diabetes and other chronic illnesses, by allowing healthcare systems to communicate with each other and monitor patients seamlessly.

, Chairman and CEO of

, said, "We are excited for this opportunity to work together with

and employ their patented technology to rapidly develop our Wireless Body platform. We believe that we are well positioned as a next generation leader in mobile health and personalized sensor tools, with the ability to wirelessly monitor patients, their vital signs and their medical devices via The Wireless Body."

The Wireless Body also has the ability to identify medical devices, currently catheter ports, to allow them to communicate with an external reader to ensure proper medication dosages and safety for the patient.